Who are in the management team of Syndax Pharmaceuticals, Inc.?

Jun 22 2025 10:34 PM IST
share
Share Via
As of March 2022, the management team of Syndax Pharmaceuticals, Inc. includes CEO Dr. Briggs Morrison, President Michael Metzger, and several independent directors, including Mr. Dennis Podlesak as Chairman. They oversee the company's operations and strategic direction.
As of March 2022, the management team of Syndax Pharmaceuticals, Inc. includes the following individuals:

- Mr. Dennis Podlesak, Independent Chairman of the Board
- Mr. Michael Metzger, President, Chief Operating Officer, Director
- Dr. Briggs Morrison, Chief Executive Officer, Director
- Dr. Fabrice Egros, Independent Director
- Ms. Jennifer Jarrett, Independent Director
- Mr. Keith Katkin, Independent Director
- Mr. Pierre Legault, Independent Director
- Mr. William Meury, Independent Director

This team is responsible for overseeing the company's operations and strategic direction.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News